GlassScriptPhysician profile
Priyanka Singh
NPI 1013112911
$1,153.35
in general payments reported to CMS, 2019-2025
19 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $42.56 · 2021: $248 · 2022: $162 · 2023: $265 · 2024: $79.20 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.24 | 2022-2025 | Jardiance |
| Amgen INC. | $160.16 | 2023 | Otezla, Repatha |
| Novo Nordisk INC | $130.97 | 2019-2024 | Wegovy, Rybelsus, Ozempic |
| Eisai INC. | $124.22 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $121.19 | 2021 | |
| Acclarent, INC | $112.79 | 2021 | |
| Ironwood Pharmaceuticals, INC | $55.53 | 2023 | Linzess |
| Jazz Pharmaceuticals INC. | $41.23 | 2019 | |
| Pfizer INC. | $33.62 | 2023-2024 | |
| Braintree Laboratories, INC. | $32.22 | 2022-2024 | Suflave |
| Glaxosmithkline, LLC. | $29.40 | 2020-2022 | |
| Sanofi Pasteur INC. | $28.24 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.51 | 2022 | |
| Harmony Biosciences LLC | $14.95 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.22 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.68 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.28 | 2024 | Voquezna |
| Astellas Pharma US INC | $12.59 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.